Skip to main content Skip to main navigation menu Skip to site footer
Research Articles
Published: 2020-02-07

Current state of management of hiv-infected patients with digestive system comorbid pathology: analysis of physicians’ survey

Bogomolets National Medical University
HIV infection digestive system family medicine

Abstract

Introduction. The HIV epidemic, which affects millions of people in eastern Europe, remains one of the most important unresolved health issues. A patient-oriented approach to HIV-infected people improves the quality of medical care, affects the reliability of statistics, streamlines the planning and adequacy of public funds. The issues of comorbidity of the pathology of the digestive system in HIV infection and the formation of adherence to effective antiretroviral therapy (ART) are becoming particularly relevant. As a result, the role of family medicine practice in the detection, treatment, and management of gastrointestinal diseases in HIV-infected patients in Ukraine is growing.

The purpose of the study: To study the role of general practitioners in family medicine in the examination and management of HIV-infected people with concomitant pathology of the digestive system.

Material and methods. A survey was conducted among 200 general practitioners of family medicine (GPFM) and 292 physicians - limited specialists of a number of health care facilities in Kyiv and various regions of Ukraine by dint of a questionnaire developed through an internet survey and paper-based.

Results and discussion. General practitioners of family medicine noted rather low participation in the monitoring of compliance and side effects of ART, as well as the management of concomitant pathology of the digestive system (DS) in HIV-infected patients. Most of the surveyed physicians noted the lack of clear algorithms for action in the development of clinical routes of HIV-infected patients with concomitant pathology of the DS and almost all respondents confirmed the feasibility of using in their current practice algorithms developed for such patients. The vast majority of GPFM didn’t fully know the ways of movement HIV-infected patients from diagnosis to a stable virological/immunological response and, thus, were not able to fully manage the concomitant pathology of DS. HIV-infected patients who underwent and reacted negatively to ART didn’t return to GPFM and therefore didn’t receive adequate, continuous, comprehensive, and coordinated medical care for various DS pathologies. Returning of HIV-infected patients from limited specialists to GPFM has been low, sporadic, which may explain the decline in the ability of GPFM’s to effectively monitor the clinical outcomes of treatment of DS pathology and ART therapy side effects.

Conclusion. Find out some of the problems on detection of DS pathology in HIV-infected people and further management tactics of such patients have been clarified. Due to the inconsistency and insufficient volume of screening for comorbid pathology of the DS organs in HIV-infected patients, many chronic pathologies remain undetected in the practice of GPFM. The presence of untreated comorbid diseases of the DS organs in HIV infection may be a risk factor for reduced effectiveness of ART in such patients. Therefore, special attention of family physicians should be paid to the timely detection, treatment, and monitoring of HIV diseases in HIV-infected patients. It is considered expedient to introduce clear algorithms of joint actions of GPFM and limited specialists involved in the management of HIV-infected patients with concomitant DS pathology.

Full-text of the article is available for this locale: Українська.

References

  1. HIV/AIDS surveillance in Europe 2019 – 2018 data. HIV/AIDS surveillance in Europe 2019 – 2018 data. https://www.ecdc.europa.eu/sites/default/files/documents/hiv-surveillance-report-2019.pdf.
  2. Nakaz MOZ Ukrainy vid 05.06.2019 № 1292 Pro zatverdzhennia novoho Klinichnoho protokolu iz zastosuvannia antyretrovirusnykh preparativ dlia likuvannia ta profilaktyky VIL-infektsii. http://moz.gov.ua/article/ministry-mandates/nakaz-moz-ukraini-vid-05062019--1292-pro-zatverdzhennja-novogo-klinichnogo-protokolu-iz-zastosuvannja-antiretrovirusnih-preparativ-dlja-likuvannja-ta-profilaktiki-vil-infekcii.
  3. HIV Infection in Ukraine. Informatsiynuy Buleten. 2020;(51). https://phc.org.ua/sites/default/files/users/user90/HIV_in_UA_51_2020.pdf.
  4. Samji H, Cescon A, Hogg RS, Modur SP, Althoff KN, Buchacz K, Burchell AN, Cohen M, Gebo KA, Gill MJ, Justice A, Kirk G, Klein MB, Korthuis PT, Martin J, Napravnik S, Rourke SB, Sterling TR, Silverberg MJ, Deeks S, Jacobson LP, Bosch RJ, Kitahata MM, Goedert JJ, Moore R, Gange SJ. Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada. Okulicz JF, ред. PLoS ONE. 2013;8(12). doi:https://doi.org/10.1371/journal.pone.0081355
  5. Neuhaus J, Angus B, Kowalska JD, Rosa A, Sampson J, Wentworth D, Mocroft A. Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV. AIDS. 2010;24(5). doi:https://doi.org/10.1097/QAD.0b013e3283365356
  6. Akhmedzhanova Z, Urunova D, Isaeva G. Rasprostranennost i chastota soputstvuyuschih i opportunisticheskih zabolevaniy na raznyih stadiyah VICh-infektsii. Zhurn. teoretich. i klin. Meditsinyi. 2015;4.
  7. Piroth L. Liver steatosis in HIV-infected patients. Aids Reviews. 2005;7(4).
  8. Alekseeva A, Nguen I, U K. Dynamika vyiavlennia deiakykh suputnikh patolohii ta staniv u osib z vpershe vstanovlenym diahnozom VIL-infektsii v Ukraini. Profilaktychna medytsyna. 2016;26(1).
  9. Hetman L, Voronova K, Riabinchuk M. Otsinka klinichnykh kompetentsii medychnykh pratsivnykiv zakladiv okhorony zdorovia, shcho nadaiut antyretrovirusnu terapiiu. Profilaktychna medytsyna. 2016;26(1).
  10. Nakaz MOZ Ukrainy vid 05.08.2014 № 509 Pro zatverdzhennia Zmin do Typovoho polozhennia pro kabinet "Dovira". Published online 2014.
  11. Golubovskaya О. Problemyi okazaniya meditsinskoy pomoschi bolnyim VICh-infektsiey i virusnyimi gepatitami v Ukraine. Klinicheskaya infektologiya i parazitologiya. 2013;(4).
  12. Vysotska O, Holubovska O. Aktualni pytannia protydii poshyrenniu sotsialno-nebezpechnykh hemokontaktnykh virusnykh infektsii v suchasnii systemi hromadskoho zdorovia Ukrainy: rol pervynnoi medychnoi dopomohy. Ukraina. Zdorovia natsii. 2018;(3).
  13. Landon BE. Physician Specialization and the Quality of Care for Human Immunodeficiency Virus Infection. Archives of Internal Medicine. 2005;165(10). doi:https://doi.org/10.1001/archinte.165.10.1133
  14. Nanditha NGA, St-Jean M, Tafessu H, Guillemi SA, Hull MW, Lu M, Henry B, Barrios R, Montaner JSG, Lima VD. Missed opportunities for earlier diagnosis of HIV in British Columbia, Canada: A retrospective cohort study. Sued O, ред. PLOS ONE. 2019;14(3). doi:https://doi.org/10.1371/journal.pone.0214012
  15. Rogowska-Szadkowska D, Strumiło J, Chlabicz S. Knowledge of family medicine trainers concerning HIV/AIDS – pilot study. Przeglad epidemiologiczny. 2017;71(4).
  16. Traversy G, Austin T, Yau J, Timmerman K. Assessing uptake of national HIV screening and testing guidance—Part 1: Awareness, use and usefulness. Canada Communicable Disease Report. 2017;43(12). doi:https://doi.org/10.14745/ccdr.v43i12a03

How to Cite

1.
Висоцький В. Current state of management of hiv-infected patients with digestive system comorbid pathology: analysis of physicians’ survey. PMGP [Internet]. 2020Feb.7 [cited 2021Dec.9];5(1). Available from: https://e-medjournal.com/index.php/psp/article/view/258